| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b7c035d67e5304c3d4b860ae2d47879 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C401-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 |
| filingDate |
1992-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac41f76b39abd4ea1d35505083e9aac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d29b7d43b595b2f0548c1fb8fef04ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81d3c6f1698321909d4f2ed5fe22e172 |
| publicationDate |
2005-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2121678-C |
| titleOfInvention |
Vitamin d amide derivatives |
| abstract |
Novel 1.alpha.-hydroxy vitamin D derivatives and their 20-epi analogues, comprising compounds of formula (I) and corresponding 5,6-trans isomers, where Y represents an alkylene or alkenylene group containing up to 4 carbon atoms; R1 and R2 independently represent a hydrogen atom or a lower alkyl or cycloalkyl group or R1R2N-represents a heterocyclic group; and R3 and R4 independently represent a hydrogen atom or an O-protecting group. Active compounds, in which R3 and R4 are hydrogen atoms or metabolically labile O-protecting groups exhibit potent cell modulating effect but minimal effect on calcium metabolism. |
| priorityDate |
1991-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |